Reach Separations Celebrate 5th Birthday
Reach Separations is celebrating its 5th anniversary with a record year of growth.
Reach Separations is celebrating its 5th anniversary with a record year of growth.
Headquartered at BioCity in Nottingham, UK, the company has carved out a niche for itself in the purification services space by supporting research chemists and scientists and establishing itself as a reliable chromatography purification provider.
“We are delighted with the progress the company has made since we started,” said Phil Abbott, Reach Separations Technical Director, and former Separation Science Group Leader at AstraZeneca. “Once we get the opportunity to work with a new chemistry group, they then tend to use us again and again as they know they can rely on our team” he continued.
The company has grown to employ 10 people and is currently recruiting for several new positions to support its expansion plans in 2017.
“We will certainly be on the lookout for talented scientists over the next year that we will train to become highly skilled chromatographers,” said Abbot. “We also have plans to make further investment in technology and equipment that will raise the bar even further,” he added.
Aimed at small molecule development projects, the company supports clients in the fields of chiral, reversed phase, and normal phase chromatography.
For more information on Reach Separations please visit: www.reachseparations.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
